Inovio Pharmaceuticals
INO
#8267
Rank
NZ$0.57 B
Marketcap
NZ$3.08
Share price
3.68%
Change (1 day)
-12.16%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -NZ$0.15 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.17 Billion, an increase over its 2024 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.15 Billion-12.6%
2025 -NZ$0.17 Billion-16.07%
2024 -NZ$0.2 Billion-20.03%
2023 -NZ$0.25 Billion-51.56%
2022 -NZ$0.51 Billion-8.26%
2021 -NZ$0.55 Billion95.4%
2020 -NZ$0.29 Billion36.62%
2019 -NZ$0.21 Billion20.19%
2018 -NZ$0.18 Billion10.94%
2017 -NZ$0.16 Billion9.59%
2016 -NZ$0.15 Billion118.9%
2015 -NZ$64.22 Million-10.67%
2014 -NZ$71.89 Million83.32%
2013 -NZ$39.22 Million
2011 -NZ$40.46 Million15.64%
2010 -NZ$34.99 Million37.7%
2009 -NZ$25.41 Million2.19%
2008 -NZ$24.86 Million-14.09%
2007 -NZ$28.94 Million19.12%
2006 -NZ$24.3 Million9.62%
2005 -NZ$22.16 Million5.77%
2004 -NZ$20.95 Million73.08%
2003 -NZ$12.11 Million12.75%
2002 -NZ$10.74 Million
2000 -NZ$16.25 Million53.93%
1999 -NZ$10.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.07 B-22,845.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$23.01 B-15,460.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.68 B-8,565.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$4.62 Billion 2,977.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.23 B-8,268.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.02 B-8,792.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-NZ$5.01 Million-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.3 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA